review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Paul Dean | Q57269178 |
P2860 | cites work | Capping of actin filaments by vinculin activated by the Shigella IpaA carboxyl-terminal domain | Q24296359 |
Structural mimicry for vinculin activation by IpaA, a virulence factor of Shigella flexneri | Q24296380 | ||
Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly | Q24307857 | ||
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase | Q24313174 | ||
Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation | Q24315675 | ||
Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein | Q24315859 | ||
AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling | Q24318895 | ||
A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling | Q24338298 | ||
Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology | Q24534908 | ||
Not all J domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions | Q24644464 | ||
Structure and distribution of pentapeptide repeats in bacteria | Q24673061 | ||
An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination | Q24678382 | ||
The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration | Q27316052 | ||
Sequence-based prediction of type III secreted proteins | Q27317165 | ||
How the Pseudomonas aeruginosa ExoS toxin downregulates Rac | Q27629091 | ||
Crystal structure of the Yersinia pestis GTPase activator YopE | Q27637326 | ||
Shigella protein IpaH(9.8) is secreted from bacteria within mammalian cells and transported to the nucleus | Q46202980 | ||
The amino-terminal non-catalytic region of Salmonella typhimurium SigD affects actin organization in yeast and mammalian cells | Q46694995 | ||
Host-mediated phosphorylation of type III effector AvrPto promotes Pseudomonas virulence and avirulence in tomato. | Q46884639 | ||
A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. | Q46898413 | ||
Effector proteins encoded by Salmonella pathogenicity island 2 interfere with the microtubule cytoskeleton after translocation into host cells | Q47757738 | ||
AvrXa10 contains an acidic transcriptional activation domain in the functionally conserved C terminus | Q47796484 | ||
Biophysical characterization of the catalytic domain of guanine nucleotide exchange factor BopE from Burkholderia pseudomallei. | Q47824038 | ||
Two novel proteins, PopB, which has functional nuclear localization signals, and PopC, which has a large leucine-rich repeat domain, are secreted through the hrp-secretion apparatus of Ralstonia solanacearum | Q47863693 | ||
GTPase-activating proteins and their complexes. | Q47959655 | ||
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells | Q48042079 | ||
Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. | Q50066742 | ||
Analysis of functional domains present in the N-terminus of the SipB protein. | Q50068971 | ||
Salmonella type III effectors PipB and PipB2 are targeted to detergent-resistant microdomains on internal host cell membranes. | Q50103373 | ||
Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. | Q50107182 | ||
A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. | Q50124353 | ||
Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. | Q50127062 | ||
IpaA targets beta1 integrins and rho to promote actin cytoskeleton rearrangements necessary for Shigella entry. | Q50710653 | ||
Dimerization of the bacterial effector protein AvrBs3 in the plant cell cytoplasm prior to nuclear import. | Q50772960 | ||
Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins. | Q52540113 | ||
The pseudomonas AvrPto protein is differentially recognized by tomato and tobacco and is localized to the plant plasma membrane. | Q52541964 | ||
Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. | Q52546261 | ||
The Pseudomonas syringae pv. tomato DC3000 type III effector HopF2 has a putative myristoylation site required for its avirulence and virulence functions. | Q52569219 | ||
Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin. | Q53607803 | ||
Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. | Q53898008 | ||
Type III-dependent translocation of the Xanthomonas AvrBs3 protein into the plant cell. | Q53956677 | ||
A carboxy-terminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion. | Q54492076 | ||
Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells. | Q54569560 | ||
Eukaryotic Fatty Acylation Drives Plasma Membrane Targeting and Enhances Function of Several Type III Effector Proteins from Pseudomonas syringae | Q57266282 | ||
A type III effector ADP-ribosylates RNA-binding proteins and quells plant immunity | Q59049221 | ||
AeromonasExoenzyme T ofAeromonas salmonicidaIs a Bifunctional Protein That Targets the Host Cytoskeleton | Q59271393 | ||
The Salmonella effector protein PipB2 is a linker for kinesin-1 | Q35037325 | ||
Dissecting the catalytic mechanism of protein-tyrosine phosphatases | Q35063279 | ||
OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence | Q35073836 | ||
A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. | Q35106240 | ||
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. | Q35107685 | ||
Chlamydial TARP is a bacterial nucleator of actin | Q35108349 | ||
Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. | Q35114802 | ||
Physical interaction between RRS1-R, a protein conferring resistance to bacterial wilt, and PopP2, a type III effector targeted to the plant nucleus | Q35147632 | ||
A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. | Q35206375 | ||
SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. | Q35645616 | ||
Getting into position: the catalytic mechanisms of protein ubiquitylation | Q35681247 | ||
Myristoylation of viral and bacterial proteins | Q35722249 | ||
The adenylate cyclase toxins | Q35921318 | ||
Process of protein transport by the type III secretion system | Q35980175 | ||
AvrPtoB: a bacterial type III effector that both elicits and suppresses programmed cell death associated with plant immunity | Q36083138 | ||
The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family | Q36167740 | ||
Substrate recognition of type III secretion machines--testing the RNA signal hypothesis. | Q36228152 | ||
Tyrosine-phosphorylated bacterial effector proteins: the enemies within | Q36229117 | ||
Type III secretion: more systems than you think | Q36262580 | ||
A Salmonella protein causes macrophage cell death by inducing autophagy | Q36324680 | ||
Cytoskeletal rearrangements and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells | Q36382504 | ||
Dynamic nuclear pore complexes: life on the edge. | Q36508009 | ||
Reciprocal secretion of proteins by the bacterial type III machines of plant and animal pathogens suggests universal recognition of mRNA targeting signals | Q36559367 | ||
Catching a GEF by its tail | Q36663439 | ||
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system | Q36809802 | ||
Type III secretion systems and disease | Q36969851 | ||
Metropolitan microbes: type III secretion in multihost symbionts | Q37001780 | ||
A family of bacterial cysteine protease type III effectors utilizes acylation-dependent and -independent strategies to localize to plasma membranes. | Q37257375 | ||
Common themes in the design and function of bacterial effectors | Q37312444 | ||
Multiple activities of the plant pathogen type III effector proteins WtsE and AvrE require WxxxE motifs | Q37356201 | ||
Pseudomonas syringae type III secretion system effectors: repertoires in search of functions | Q37377069 | ||
Ubiquitination of the bacterial inositol phosphatase, SopB, regulates its biological activity at the plasma membrane. | Q37387728 | ||
Pathogen trafficking pathways and host phosphoinositide metabolism. | Q37390009 | ||
Actin filament nucleation and elongation factors--structure-function relationships | Q37455891 | ||
The crystal structure of Pseudomonas avirulence protein AvrPphB: A papain-like fold with a distinct substrate-binding site | Q27642849 | ||
Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase | Q27649217 | ||
Crystal structure of SopA, a Salmonella effector protein mimicking a eukaryotic ubiquitin ligase | Q27649240 | ||
Structural and Functional Studies Indicate That Shigella VirA Is Not a Protease and Does Not Directly Destabilize Microtubules ‡ | Q27651916 | ||
Novel fold of VirA, a type III secretion system effector protein fromShigella flexneri | Q27652112 | ||
Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation | Q27652828 | ||
Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases | Q27652850 | ||
Structure of a Shigella effector reveals a new class of ubiquitin ligases | Q27652851 | ||
Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics | Q27656575 | ||
Computational prediction of type III and IV secreted effectors in gram-negative bacteria | Q27692827 | ||
Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate | Q27730850 | ||
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains | Q27860528 | ||
Mechanisms underlying ubiquitination | Q27860656 | ||
SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box | Q27936367 | ||
PDZ domains: structural modules for protein complex assembly | Q28210680 | ||
The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions | Q28239729 | ||
A simple cipher governs DNA recognition by TAL effectors | Q28265506 | ||
Breaking the code of DNA binding specificity of TAL-type III effectors | Q28265515 | ||
A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant | Q28266681 | ||
The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane | Q28286030 | ||
GDSL family of serine esterases/lipases | Q28291336 | ||
GEFs and GAPs: critical elements in the control of small G proteins | Q28304540 | ||
SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase | Q28369269 | ||
The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction | Q28474712 | ||
The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase | Q28490017 | ||
SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host cells | Q28490058 | ||
Involvement of targeted proteolysis in plant genetic transformation by Agrobacterium | Q28492363 | ||
The type III effector HopF2Pto targets Arabidopsis RIN4 protein to promote Pseudomonas syringae virulence | Q28492430 | ||
A J domain virulence effector of Pseudomonas syringae remodels host chloroplasts and suppresses defenses | Q28492431 | ||
SteC is a Salmonella kinase required for SPI-2-dependent F-actin remodelling | Q28563583 | ||
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors | Q29547630 | ||
Protein import into mitochondria | Q29620420 | ||
A bacterial effector acts as a plant transcription factor and induces a cell size regulator | Q30319733 | ||
New type III effectors from Xanthomonas campestris pv. vesicatoria trigger plant reactions dependent on a conserved N-myristoylation motif | Q30319751 | ||
Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation | Q44668051 | ||
The J-domain family and the recruitment of chaperone power | Q45068628 | ||
Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. | Q45144471 | ||
Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin | Q45299707 | ||
Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH. | Q34462401 | ||
A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase | Q34479090 | ||
Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity. | Q34479457 | ||
Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases | Q34505359 | ||
Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation | Q34530978 | ||
Amino acids of the bacterial toxin SopE involved in G nucleotide exchange on Cdc42. | Q34533184 | ||
Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. | Q34564396 | ||
Ralstonia solanacearum requires F-box-like domain-containing type III effectors to promote disease on several host plants | Q34566984 | ||
Trafficking and signaling by fatty-acylated and prenylated proteins | Q34575170 | ||
Yersinia effectors target mammalian signalling pathways | Q34600556 | ||
Diverse evolutionary mechanisms shape the type III effector virulence factor repertoire in the plant pathogen Pseudomonas syringae | Q34645388 | ||
The discovery of SycO highlights a new function for type III secretion effector chaperones. | Q34767708 | ||
Translocated effectors of Yersinia | Q34934549 | ||
Dynamics of the WPD loop of the Yersinia protein tyrosine phosphatase | Q35023836 | ||
Arp2/3-independent assembly of actin by Vibrio type III effector VopL. | Q30365230 | ||
The Salmonella effector PipB2 affects late endosome/lysosome distribution to mediate Sif extension | Q30476107 | ||
The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. | Q30480560 | ||
The C terminus of YopT is crucial for activity and the N terminus is crucial for substrate binding | Q30813319 | ||
A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium | Q30835474 | ||
Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins | Q31146461 | ||
Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition | Q31538666 | ||
Actin is ADP-ribosylated by the Salmonella enterica virulence-associated protein SpvB. | Q31906961 | ||
S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. | Q32060838 | ||
Delineation and characterization of the actin nucleation and effector translocation activities of Salmonella SipC. | Q33212064 | ||
Membrane release and destabilization of Arabidopsis RIN4 following cleavage by Pseudomonas syringae AvrRpt2. | Q33233873 | ||
Terminal reassortment drives the quantum evolution of type III effectors in bacterial pathogens | Q33260347 | ||
Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems | Q33270514 | ||
A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo | Q33292512 | ||
Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells | Q33292526 | ||
Fido, a novel AMPylation domain common to fic, doc, and AvrB. | Q33463423 | ||
Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU | Q33558698 | ||
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN | Q33590435 | ||
The Pseudomonas syringae type III effector HopG1 targets mitochondria, alters plant development and suppresses plant innate immunity. | Q33651072 | ||
The Pseudomonas syringae effector AvrRpt2 cleaves its C-terminally acylated target, RIN4, from Arabidopsis membranes to block RPM1 activation | Q33772090 | ||
Molecular characterization of proteolytic cleavage sites of the Pseudomonas syringae effector AvrRpt2. | Q33830678 | ||
Salmonella pathogenesis and processing of secreted effectors by caspase-3 | Q33859408 | ||
The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence | Q33877120 | ||
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure | Q33904931 | ||
The Salmonella SPI-2 effector SseJ exhibits eukaryotic activator-dependent phospholipase A and glycerophospholipid : cholesterol acyltransferase activity | Q33913059 | ||
SseJ deacylase activity by Salmonella enterica serovar Typhimurium promotes virulence in mice | Q34033443 | ||
Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila | Q34044433 | ||
Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence | Q34045022 | ||
The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes | Q34048081 | ||
Pseudomonas syringae hijacks plant stress chaperone machinery for virulence. | Q34059507 | ||
EseG, an effector of the type III secretion system of Edwardsiella tarda, triggers microtubule destabilization. | Q34309741 | ||
Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases | Q34328046 | ||
Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway | Q34356501 | ||
Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung | Q37624028 | ||
The EspF effector, a bacterial pathogen's Swiss army knife | Q37777278 | ||
Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigD. | Q38308519 | ||
Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization | Q39647502 | ||
Analyses of the evolutionary distribution of Salmonella translocated effectors | Q39654360 | ||
The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. | Q39807355 | ||
SseG, a virulence protein that targets Salmonella to the Golgi network | Q39927890 | ||
Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. | Q39996509 | ||
Identification of a molecular target for the Yersinia protein kinase A. | Q40127331 | ||
The phosphothreonine lyase activity of a bacterial type III effector family | Q40170436 | ||
Yersinia protein kinase YopO is activated by a novel G-actin binding process | Q40205460 | ||
Mutational analysis of Salmonella translocated effector members SifA and SopD2 reveals domains implicated in translocation, subcellular localization and function | Q40253886 | ||
The proteasome pathway destabilizes Yersinia outer protein E and represses its antihost cell activities | Q40284396 | ||
Identification of a bacterial type III effector family with G protein mimicry functions. | Q40329601 | ||
A Salmonella typhimurium effector protein SifA is modified by host cell prenylation and S-acylation machinery. | Q40458340 | ||
TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton | Q40495870 | ||
Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus | Q40508871 | ||
Identification of a nuclear targeting signal in YopM from Yersinia spp. | Q40573814 | ||
The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities. | Q40582422 | ||
EspM2 is a RhoA guanine nucleotide exchange factor | Q40593889 | ||
Characterization of YopT effects on Rho GTPases in Yersinia enterocolitica-infected cells. | Q40641826 | ||
Potential role of the EPEC translocated intimin receptor (Tir) in host apoptotic events | Q40645212 | ||
Salmonella typhimurium SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its biological function | Q40672000 | ||
Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. | Q40705607 | ||
The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis | Q40826505 | ||
Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. | Q40840610 | ||
A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium | Q41178388 | ||
Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells | Q41207631 | ||
The Ser/Thr kinase activity of the Yersinia protein kinase A (YpkA) is necessary for full virulence in the mouse, mollifying phagocytes, and disrupting the eukaryotic cytoskeleton | Q41454206 | ||
Proteomic and functional analysis of the suite of Ysp proteins exported by the Ysa type III secretion system of Yersinia enterocolitica Biovar 1B. | Q41455571 | ||
Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence | Q41459412 | ||
Site-specific antiphagocytic function of the Photorhabdus luminescens type III secretion system during insect colonization | Q41459779 | ||
Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells | Q41465027 | ||
A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. | Q41471661 | ||
Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals | Q41477291 | ||
The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1. | Q41478052 | ||
The Yersinia protein kinase A is a host factor inducible RhoA/Rac-binding virulence factor | Q41478563 | ||
The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence | Q41478657 | ||
Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems | Q41481295 | ||
Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus | Q41483776 | ||
Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo | Q41769175 | ||
Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. | Q41810065 | ||
The HopZ family of Pseudomonas syringae type III effectors require myristoylation for virulence and avirulence functions in Arabidopsis thaliana | Q41858898 | ||
The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector | Q41971348 | ||
A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells | Q42581042 | ||
Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. | Q42618086 | ||
Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. | Q42620637 | ||
Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella | Q42680869 | ||
The Salmonella translocated effector SopA is targeted to the mitochondria of infected cells | Q42754908 | ||
A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity | Q43072304 | ||
The Salmonella effector SptP dephosphorylates host AAA+ ATPase VCP to promote development of its intracellular replicative niche | Q43074065 | ||
The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells | Q43548955 | ||
A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation | Q43580834 | ||
The Pseudomonas syringae type III effector tyrosine phosphatase HopAO1 suppresses innate immunity in Arabidopsis thaliana. | Q43801273 | ||
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. | Q43872729 | ||
Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane | Q43982253 | ||
SifA, a type III secreted effector of Salmonella typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. | Q43993314 | ||
Salmonella enterica serovar Typhimurium effector SigD/SopB is membrane-associated and ubiquitinated inside host cells | Q44053307 | ||
The Pseudomonas syringae type III-secreted protein HopPtoD2 possesses protein tyrosine phosphatase activity and suppresses programmed cell death in plants | Q44492738 | ||
In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors | Q44547313 | ||
Genetic and molecular evidence that the Pseudomonas syringae type III effector protein AvrRpt2 is a cysteine protease | Q44570299 | ||
Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. | Q44655603 | ||
P433 | issue | 6 | |
P304 | page(s) | 1100-1125 | |
P577 | publication date | 2011-05-18 | |
P1433 | published in | FEMS Microbiology Reviews | Q15762226 |
P1476 | title | Functional domains and motifs of bacterial type III effector proteins and their roles in infection | |
P478 | volume | 35 |
Q38164827 | 'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics |
Q28822572 | 3'-NADP and 3'-NAADP - Two Metabolites Formed by the Bacterial Type III Effector AvrRxo1 |
Q34782161 | A Ralstonia solanacearum type III effector directs the production of the plant signal metabolite trehalose-6-phosphate |
Q30313747 | A TAL-Based Reporter Assay for Monitoring Type III-Dependent Protein Translocation in Xanthomonas |
Q33894883 | A Transcription Activator-Like Effector Tal7 of Xanthomonas oryzae pv. oryzicola Activates Rice Gene Os09g29100 to Suppress Rice Immunity |
Q37013790 | A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation |
Q41847635 | A bacterial encoded protein induces extreme multinucleation and cell-cell internalization in intestinal cells |
Q41791830 | A bacterial tyrosine phosphatase inhibits plant pattern recognition receptor activation |
Q41381322 | A novel type 3 secretion system effector, YspI of Yersinia enterocolitica, induces cell paralysis by reducing total focal adhesion kinase |
Q46272948 | A proteome view of structural, functional, and taxonomic characteristics of major protein domain clusters |
Q34081736 | A simple yeast-based strategy to identify host cellular processes targeted by bacterial effector proteins |
Q28538799 | A substrate-fusion protein is trapped inside the Type III Secretion System channel in Shigella flexneri |
Q40080289 | A systematic analysis of the RNA-targeting potential of secreted bacterial effector proteins |
Q38151981 | Aeromonas salmonicida subsp. salmonicida in the light of its type-three secretion system |
Q104581364 | All Roads Lead to Susceptibility: The Many Modes of Action of Fungal and Oomycete Intracellular Effectors |
Q35152952 | Amoebal endosymbiont Neochlamydia genome sequence illuminates the bacterial role in the defense of the host amoebae against Legionella pneumophila |
Q41362622 | Analysis of Type III Secretion System Secreted Proteins |
Q34447679 | Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. |
Q38366322 | Approaches targeting the type III secretion system to treat or prevent bacterial infections |
Q35668738 | Asian Citrus Psyllid Expression Profiles Suggest Candidatus Liberibacter Asiaticus-Mediated Alteration of Adult Nutrition and Metabolism, and of Nymphal Development and Immunity |
Q46854918 | AvrXa7-Xa7 mediated defense in rice can be suppressed by transcriptional activator-like effectors TAL6 and TAL11a from Xanthomonas oryzae pv. oryzicola |
Q35789603 | BEAN 2.0: an integrated web resource for the identification and functional analysis of type III secreted effectors |
Q27026776 | Bacterial pathogens commandeer Rab GTPases to establish intracellular niches |
Q34639643 | Bacterial secreted effectors and caspase-3 interactions |
Q28068755 | Behind the lines-actions of bacterial type III effector proteins in plant cells |
Q28535610 | BtcA, A class IA type III chaperone, interacts with the BteA N-terminal domain through a globular/non-globular mechanism |
Q50114639 | CLIQ-BID: A method to quantify bacteria-induced damage to eukaryotic cells by automated live-imaging of bright nuclei. |
Q40601360 | CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity |
Q28485367 | Characterization of the N-terminal domain of BteA: a Bordetella type III secreted cytotoxic effector |
Q44080780 | Characterization of the SPI-1 and Rsp type three secretion systems in Pseudomonas fluorescens F113. |
Q46342451 | Comparative and bioinformatics analyses of pathogenic bacterial secretomes identified by mass spectrometry in Burkholderia species. |
Q34751198 | Comparative genomics of Salmonella enterica serovars Derby and Mbandaka, two prevalent serovars associated with different livestock species in the UK |
Q38023077 | Computational analysis of interactomes: current and future perspectives for bioinformatics approaches to model the host-pathogen interaction space. |
Q36228807 | Computational approach to predict species-specific type III secretion system (T3SS) effectors using single and multiple genomes |
Q27681220 | Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycD in complex with a peptide of the minor translocator YopD |
Q37150632 | Detecting N-myristoylation and S-acylation of host and pathogen proteins in plants using click chemistry |
Q64903496 | Edwardsiella piscicida Type III Secretion System Effector EseK Inhibits Mitogen-Activated Protein Kinase Phosphorylation and Promotes Bacterial Colonization in Zebrafish Larvae. |
Q92248420 | Edwardsiella piscicida: A versatile emerging pathogen of fish |
Q35082975 | Effective identification of Gram-negative bacterial type III secreted effectors using position-specific residue conservation profiles |
Q30356927 | Effector proteins support the asymmetric apportioning of Salmonella during cytokinesis. |
Q37167670 | Effectors of animal and plant pathogens use a common domain to bind host phosphoinositides |
Q35091765 | Electroporation of functional bacterial effectors into mammalian cells |
Q47126937 | Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy |
Q90424649 | EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains |
Q34073801 | Expression of the bacterial type III effector DspA/E in Saccharomyces cerevisiae down-regulates the sphingolipid biosynthetic pathway leading to growth arrest. |
Q34395262 | Five mechanisms of manipulation by bacterial effectors: a ubiquitous theme |
Q39235366 | Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome |
Q38633520 | Gene and transcript abundances of bacterial type III secretion systems from the rumen microbiome are correlated with methane yield in sheep |
Q40988760 | Genome Sequence of Xanthomonas arboricola pv. Corylina, Isolated from Turkish Filbert in Colorado |
Q47236641 | Genomic features of bacterial adaptation to plants. |
Q37337255 | Genus-optimized strategy for the identification of chlamydial type III secretion substrates |
Q26853211 | Greasy tactics in the plant-pathogen molecular arms race |
Q36094297 | High-throughput genomic sequencing of cassava bacterial blight strains identifies conserved effectors to target for durable resistance |
Q44862586 | Host-induced gene silencing: a tool for understanding fungal host interaction and for developing novel disease control strategies. |
Q37527203 | How Bacteria Subvert Animal Cell Structure and Function |
Q39682266 | Identification and Characterization of Putative Translocated Effector Proteins of the Edwardsiella ictaluri Type III Secretion System |
Q92515642 | Identification and characterization of putative Aeromonas spp. T3SS effectors |
Q35815841 | Identification of Critical Amino Acids Conferring Lethality in VopK, a Type III Effector Protein of Vibrio cholerae: Lessons from Yeast Model System |
Q37349637 | Identification of Novel Host Interactors of Effectors Secreted by Salmonella and Citrobacter. |
Q36281571 | Identification of effector-like proteins in Trichoderma spp. and role of a hydrophobin in the plant-fungus interaction and mycoparasitism |
Q33653604 | Identification of microsporidia host-exposed proteins reveals a repertoire of rapidly evolving proteins |
Q41143271 | Identification of novel Xanthomonas euvesicatoria type III effector proteins by a machine-learning approach |
Q37168437 | Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase |
Q39180064 | Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike |
Q58692386 | Impact of Salmonella enterica Type III Secretion System Effectors on the Eukaryotic Host Cell |
Q40509277 | Inhibition of WAVE Regulatory Complex Activation by a Bacterial Virulence Effector Counteracts Pathogen Phagocytosis |
Q35148051 | Interaction between the type III effector VopO and GEF-H1 activates the RhoA-ROCK pathway |
Q35842267 | Interaction of Arabidopsis Trihelix-Domain Transcription Factors VFP3 and VFP5 with Agrobacterium Virulence Protein VirF. |
Q55644920 | Intracellular Bacterial Infections: A Challenge for Developing Cellular Mediated Immunity Vaccines for Farmed Fish. |
Q42618338 | Intrinsic disorder in pathogen effectors: protein flexibility as an evolutionary hallmark in a molecular arms race. |
Q40454924 | Introduction to Type III Secretion Systems. |
Q99604969 | Keeping in Touch with Type-III Secretion System Effectors: Mass Spectrometry-Based Proteomics to Study Effector-Host Protein-Protein Interactions |
Q26822456 | Killing two birds with one stone: trans-kingdom suppression of PAMP/MAMP-induced immunity by T3E from enteropathogenic bacteria |
Q38087113 | Lost after translation: post-translational modifications by bacterial type III effectors |
Q36909558 | Magnaporthe oryzae Effector AVR-Pii Helps to Establish Compatibility by Inhibition of the Rice NADP-Malic Enzyme Resulting in Disruption of Oxidative Burst and Host Innate Immunity. |
Q41357286 | Mechanism of host substrate acetylation by a YopJ family effector. |
Q36994631 | Metabolic host responses to infection by intracellular bacterial pathogens |
Q28080342 | Microsporidia: Why Make Nucleotides if You Can Steal Them? |
Q36489643 | Mobile effector proteins on phage genomes |
Q37548120 | New frontiers in type III secretion biology: the Chlamydia perspective |
Q34868917 | New players in the same old game: a system level in silico study to predict type III secretion system and effector proteins in bacterial genomes reveals common themes in T3SS mediated pathogenesis |
Q36653379 | New technologies in developing recombinant attenuated Salmonella vaccine vectors |
Q47662391 | Novel T3SS effector EseK in Edwardsiella piscicida is chaperoned by EscH and EscS to express virulence. |
Q47254500 | Novel insights into the mechanism of SepL-mediated control of effector secretion in enteropathogenic Escherichia coli. |
Q51058305 | Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. |
Q40099941 | Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins. |
Q28542091 | Phytoplasma effector SAP54 hijacks plant reproduction by degrading MADS-box proteins and promotes insect colonization in a RAD23-dependent manner |
Q34283923 | Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics |
Q48102847 | Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome |
Q37498015 | Potential of known and short prokaryotic protein motifs as a basis for novel peptide-based antibacterial therapeutics: a computational survey. |
Q64940791 | Prediction of bacterial E3 ubiquitin ligase effectors using reduced amino acid peptide fingerprinting. |
Q39637757 | Probing the cellular effects of bacterial effector proteins with the Yersinia toolbox |
Q64234386 | Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target |
Q88011724 | Protein-Injection Machines in Bacteria |
Q39407784 | Quantitative proteomic analysis of Burkholderia pseudomallei Bsa type III secretion system effectors using hypersecreting mutants |
Q37425003 | RalF-Mediated Activation of Arf6 Controls Rickettsia typhi Invasion by Co-Opting Phosphoinositol Metabolism |
Q46904094 | Ralstonia solanacearum type III secretion system effector Rip36 induces a hypersensitive response in the nonhost wild eggplant Solanum torvum |
Q34525626 | Regulation of cell wall-bound invertase in pepper leaves by Xanthomonas campestris pv. vesicatoria type three effectors |
Q38079815 | Regulation of the Yersinia type III secretion system: traffic control |
Q30432222 | Remodeling of the intestinal brush border underlies adhesion and virulence of an enteric pathogen |
Q36727376 | RipAY, a Plant Pathogen Effector Protein, Exhibits Robust γ-Glutamyl Cyclotransferase Activity When Stimulated by Eukaryotic Thioredoxins. |
Q35621978 | SINC, a type III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and uninfected neighbors |
Q36054725 | Salmonella effectors: important players modulating host cell function during infection |
Q57114106 | Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Infection in Mice |
Q38418062 | Small regulatory RNAs and the fine-tuning of plant–bacteria interactions |
Q35907031 | Specific Gene Loci of Clinical Pseudomonas putida Isolates. |
Q37539390 | Staphylococcus aureus Infection Reduces Nutrition Uptake and Nucleotide Biosynthesis in a Human Airway Epithelial Cell Line. |
Q38309987 | Structural insight into effector proteins of Gram-negative bacterial pathogens that modulate the phosphoproteome of their host |
Q27727693 | Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family |
Q52674777 | Systematic Identification of Intracellular-Translocated Candidate Effectors in Edwardsiella piscicida. |
Q47267267 | The Agrobacterium F-box protein effector VirF destabilizes the Arabidopsis GLABROUS1 enhancer/binding protein-like transcription factor VFP4, a transcriptional activator of defense response genes |
Q41491066 | The Arf GTPase-activating protein family is exploited by Salmonella enterica serovar Typhimurium to invade nonphagocytic host cells |
Q35738591 | The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System. |
Q35856973 | The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE. |
Q37323304 | The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease |
Q39760246 | The Draft Genome Sequence of the Yersinia entomophaga Entomopathogenic Type Strain MH96T. |
Q36631422 | The Genomes of Three Uneven Siblings: Footprints of the Lifestyles of Three Trichoderma Species |
Q37575990 | The PPE2 protein of Mycobacterium tuberculosis translocates to host nucleus and inhibits nitric oxide production. |
Q30313661 | The Predicted Lytic Transglycosylase HpaH from Xanthomonas campestris pv. vesicatoria Associates with the Type III Secretion System and Promotes Effector Protein Translocation |
Q47119631 | The Ralstonia solanacearum Type III Effector RipAY Is Phosphorylated in Plant Cells to Modulate Its Enzymatic Activity |
Q27027103 | The SPI-1-like Type III secretion system: more roles than you think |
Q41198238 | The Salmonella Typhimurium effector SteC inhibits Cdc42-mediated signaling through binding to the exchange factor Cdc24 in Saccharomyces cerevisiae. |
Q35100520 | The Salmonella type III secretion system virulence effector forms a new hexameric chaperone assembly for export of effector/chaperone complexes |
Q42328253 | The bacterial type III secretion system as a target for developing new antibiotics |
Q36159095 | The effect of low shear force on the virulence potential of Yersinia pestis: new aspects that space-like growth conditions and the final frontier can teach us about a formidable pathogen |
Q42573943 | The effector AWR5 from the plant pathogen Ralstonia solanacearum is an inhibitor of the TOR signalling pathway. |
Q36211081 | The hydrophilic translocator for Vibrio parahaemolyticus, T3SS2, is also translocated |
Q35149904 | The pathogenesis, detection, and prevention of Vibrio parahaemolyticus |
Q34983708 | The role of autophagy in chloroplast degradation and chlorophagy in immune defenses during Pst DC3000 (AvrRps4) infection |
Q40987468 | The small RNA Spot 42 regulates the expression of the type III secretion system 1 (T3SS1) chaperone protein VP1682 in Vibrio parahaemolyticus |
Q40978693 | Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup V. cholerae |
Q39406159 | Type III Secretion in the Melioidosis Pathogen Burkholderia pseudomallei |
Q38019015 | Type III effector-mediated processes in Salmonella infection |
Q41504137 | Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida. |
Q92956497 | Unusual extracellular appendages deployed by the model strain Pseudomonas fluorescens C7R12 |
Q89820572 | Vibrio parahaemolyticus Infection in Mice Reduces Protective Gut Microbiota, Augmenting Disease Pathways |
Q30370521 | Vibrio parahaemolyticus strengthens their virulence through modulation of cellular reactive oxygen species in vitro. |
Q42315430 | VopE, a Vibrio cholerae Type III Effector, Attenuates the Activation of CWI-MAPK Pathway in Yeast Model System |
Q35751326 | Which Way In? The RalF Arf-GEF Orchestrates Rickettsia Host Cell Invasion |
Q26766358 | Yeast as a Heterologous Model System to Uncover Type III Effector Function |
Q41380323 | Yersinia enterocolitica type III secretion injectisomes form regularly spaced clusters, which incorporate new machines upon activation |
Q38991950 | YopJ Family Effectors Promote Bacterial Infection through a Unique Acetyltransferase Activity |
Search more.